What is the Org number of Stockholm Vaccin-Lättakut AB?

Stockholm Vaccin-Lättakut AB is registered with Bolagsverket / SCB under Org 5567798847.

What is the revenue of Stockholm Vaccin-Lättakut AB?

Stockholm Vaccin-Lättakut AB reported revenue of SEK 4,3M in 2025.

How many employees does Stockholm Vaccin-Lättakut AB have?

Stockholm Vaccin-Lättakut AB employs 3 people as of the latest annual report.

Who is the CEO of Stockholm Vaccin-Lättakut AB?

Mats-Ivar Ivarsson is Audit of Stockholm Vaccin-Lättakut AB, in role since 2022.

Who is the chairman of Stockholm Vaccin-Lättakut AB?

Ann-Sophie Gun Färnman Rörström chairs the board of Stockholm Vaccin-Lättakut AB, in role since 2022.

Where is Stockholm Vaccin-Lättakut AB headquartered?

Stockholm Vaccin-Lättakut AB's registered address is Sankt Eriksplan 6.

Riskpilot← Back to search

Sign inGet full access

Stockholm Vaccin-Lättakut AB

ABActive

Org 5567798847Sankt Eriksplan 6, 113 20 StockholmGeneral medical practice activities · NACE 8621Est. 20093 employees

Overview Financials People & ownership Related companies

Financials

Revenue

SEK millions

EBITDA

SEK millions

Income statement

SEK thousands

Item	2021	2022	2023	2024	2025
Revenue	3 959	3 463	4 473	4 364	4 270
Staff expenses	—	—	—	—	—
EBITDA	587	−325	−312	−636	177
Depreciation & amort.	−3	−3	−3	−3	−3
EBIT	584	−328	−315	−639	174
Net financials	−1	−1	—	3	2
Profit before tax	633	−29	−315	−636	176
Tax	−140	−2	−0	−0	−41
Net profit	493	−31	−315	−636	135

Balance sheet

SEK thousands

Item	2021	2022	2023	2024	2025
Total assets	2 446	2 064	1 976	1 090	1 079
Equity	1 697	1 666	1 351	714	849
Long-term debt	0	0	0	0	0
Short-term debt	449	398	625	375	230
Total debt	449	398	625	375	230

Financial ratios

5-year trend

EBITDA margin

4.1%

This company

15.8%

Market median

-74% vs market

20212025

Equity ratio

78.7%

This company

38.2%

Market median

+106% vs market

20212025

Return on equity

15.9%

This company

18.4%

Market median

+14% vs market

20212025

Net profit margin

3.2%

This company

8.1%

Market median

-60% vs market

20212025

Asset turnover

3.96×

This company

1.12×

Market median

+254% vs market

20212025

Debt / equity

0.27×

This company

0.62×

Market median

+56% vs market

20212025

Annual reports & filings

Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30

Stockholm Vaccin-Lättakut AB

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Stockholm Vaccin-Lättakut AB

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Stockholm Vaccin-Lättakut AB